ID   PGRC2_HUMAN             Reviewed;         223 AA.
AC   O15173; Q569H1;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 1.
DT   18-JUN-2025, entry version 196.
DE   RecName: Full=Membrane-associated progesterone receptor component 2 {ECO:0000305};
DE   AltName: Full=Progesterone membrane-binding protein;
DE   AltName: Full=Steroid receptor protein DG6;
GN   Name=PGRMC2 {ECO:0000312|HGNC:HGNC:16089};
GN   Synonyms=DG6 {ECO:0000303|PubMed:9705155}, PMBP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=9705155; DOI=10.1515/bchm.1998.379.7.907;
RA   Gerdes D., Wehling M., Leube B., Falkenstein E.;
RT   "Cloning and tissue expression of two putative steroid membrane
RT   receptors.";
RL   Biol. Chem. 379:907-911(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-210 AND THR-211, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90 AND THR-211, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-211, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90; SER-104; SER-208 AND
RP   THR-211, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90; SER-208 AND THR-211, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=23793472; DOI=10.1177/1933719113492208;
RA   Bunch K., Tinnemore D., Huff S., Hoffer Z.S., Burney R.O., Stallings J.D.;
RT   "Expression patterns of progesterone receptor membrane components 1 and 2
RT   in endometria from women with and without endometriosis.";
RL   Reprod. Sci. 21:190-197(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   INTERACTION WITH AAAS, AND SUBCELLULAR LOCATION.
RX   PubMed=27754849; DOI=10.1242/bio.021162;
RA   Juehlen R., Landgraf D., Huebner A., Koehler K.;
RT   "Identification of a novel putative interaction partner of the nucleoporin
RT   ALADIN.";
RL   Biol. Open 5:1697-1705(2016).
RN   [20]
RP   FUNCTION, SUBCELLULAR LOCATION, AND HEME-BINDING.
RX   PubMed=28111073; DOI=10.1016/j.cell.2016.12.029;
RA   Parker C.G., Galmozzi A., Wang Y., Correia B.E., Sasaki K., Joslyn C.M.,
RA   Kim A.S., Cavallaro C.L., Lawrence R.M., Johnson S.R., Narvaiza I.,
RA   Saez E., Cravatt B.F.;
RT   "Ligand and Target Discovery by Fragment-Based Screening in Human Cells.";
RL   Cell 168:527.E29-541.E29(2017).
RN   [21]
RP   REVIEW, FUNCTION, AND MISCELLANEOUS.
RX   PubMed=28396637; DOI=10.3389/fphar.2017.00159;
RA   Ryu C.S., Klein K., Zanger U.M.;
RT   "Membrane associated progesterone receptors: promiscuous proteins with
RT   pleiotropic functions - focus on interactions with cytochromes P450.";
RL   Front. Pharmacol. 8:159-159(2017).
RN   [22]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND GLYCOSYLATION AT SER-15.
RX   PubMed=37453717; DOI=10.1016/j.mcpro.2023.100617;
RA   Noborn F., Nilsson J., Sihlbom C., Nikpour M., Kjellen L., Larson G.;
RT   "Mapping the Human Chondroitin Sulfate Glycoproteome Reveals an Unexpected
RT   Correlation Between Glycan Sulfation and Attachment Site Characteristics.";
RL   Mol. Cell. Proteomics 22:100617-100617(2023).
CC   -!- FUNCTION: Required for the maintenance of uterine histoarchitecture and
CC       normal female reproductive lifespan (By similarity). May serve as a
CC       universal non-classical progesterone receptor in the uterus (Probable).
CC       Intracellular heme chaperone required for delivery of labile, or
CC       signaling heme, to the nucleus (By similarity). Plays a role in
CC       adipocyte function and systemic glucose homeostasis (PubMed:28111073).
CC       In brown fat, which has a high demand for heme, delivery of labile heme
CC       in the nucleus regulates the activity of heme-responsive
CC       transcriptional repressors such as NR1D1 and BACH1 (By similarity).
CC       {ECO:0000250|UniProtKB:Q80UU9, ECO:0000269|PubMed:28111073,
CC       ECO:0000305|PubMed:28396637}.
CC   -!- SUBUNIT: Interacts with PGRMC1 (By similarity). Interacts with AAAS
CC       (PubMed:27754849). {ECO:0000250|UniProtKB:Q80UU9,
CC       ECO:0000269|PubMed:27754849}.
CC   -!- INTERACTION:
CC       O15173; Q96PS8: AQP10; NbExp=3; IntAct=EBI-1050125, EBI-12820279;
CC       O15173; Q96L15: ART5; NbExp=3; IntAct=EBI-1050125, EBI-50185646;
CC       O15173; O95429: BAG4; NbExp=5; IntAct=EBI-1050125, EBI-2949658;
CC       O15173; P01031: C5; NbExp=3; IntAct=EBI-1050125, EBI-8558308;
CC       O15173; Q5RI15: COX20; NbExp=3; IntAct=EBI-1050125, EBI-2834035;
CC       O15173; O14569: CYB561D2; NbExp=3; IntAct=EBI-1050125, EBI-717654;
CC       O15173; P78329: CYP4F2; NbExp=3; IntAct=EBI-1050125, EBI-1752413;
CC       O15173; Q6ZPD8: DGAT2L6; NbExp=3; IntAct=EBI-1050125, EBI-12831978;
CC       O15173; Q8N5I4: DHRSX; NbExp=3; IntAct=EBI-1050125, EBI-3923585;
CC       O15173; O14681: EI24; NbExp=3; IntAct=EBI-1050125, EBI-2339413;
CC       O15173; Q7L5A8: FA2H; NbExp=3; IntAct=EBI-1050125, EBI-11337888;
CC       O15173; Q96IV6: FAXDC2; NbExp=3; IntAct=EBI-1050125, EBI-12142299;
CC       O15173; Q9H0Q3: FXYD6; NbExp=3; IntAct=EBI-1050125, EBI-713304;
CC       O15173; O43681: GET3; NbExp=3; IntAct=EBI-1050125, EBI-2515857;
CC       O15173; Q9H3K2: GHITM; NbExp=3; IntAct=EBI-1050125, EBI-2868909;
CC       O15173; Q8TDV0: GPR151; NbExp=3; IntAct=EBI-1050125, EBI-11955647;
CC       O15173; P11215: ITGAM; NbExp=3; IntAct=EBI-1050125, EBI-2568251;
CC       O15173; Q8IWB1: ITPRIP; NbExp=4; IntAct=EBI-1050125, EBI-2556412;
CC       O15173; Q9UBY5: LPAR3; NbExp=3; IntAct=EBI-1050125, EBI-12033434;
CC       O15173; Q13021: MALL; NbExp=3; IntAct=EBI-1050125, EBI-750078;
CC       O15173; Q9Y4C4: MFHAS1; NbExp=2; IntAct=EBI-1050125, EBI-2864441;
CC       O15173; Q6N075: MFSD5; NbExp=3; IntAct=EBI-1050125, EBI-3920969;
CC       O15173; Q9P0S3: ORMDL1; NbExp=3; IntAct=EBI-1050125, EBI-1054848;
CC       O15173; I3L0A0: PEDS1-UBE2V1; NbExp=3; IntAct=EBI-1050125, EBI-12213001;
CC       O15173; Q9Y5Y5: PEX16; NbExp=3; IntAct=EBI-1050125, EBI-981985;
CC       O15173; O00264: PGRMC1; NbExp=4; IntAct=EBI-1050125, EBI-1045534;
CC       O15173; Q9Y342: PLLP; NbExp=3; IntAct=EBI-1050125, EBI-3919291;
CC       O15173; Q01453: PMP22; NbExp=3; IntAct=EBI-1050125, EBI-2845982;
CC       O15173; O76064: RNF8; NbExp=3; IntAct=EBI-1050125, EBI-373337;
CC       O15173; Q96GQ5: RUSF1; NbExp=3; IntAct=EBI-1050125, EBI-8636004;
CC       O15173; Q9H9B4: SFXN1; NbExp=3; IntAct=EBI-1050125, EBI-355861;
CC       O15173; Q7RTY0: SLC16A13; NbExp=3; IntAct=EBI-1050125, EBI-12243266;
CC       O15173; Q8IWU4: SLC30A8; NbExp=3; IntAct=EBI-1050125, EBI-10262251;
CC       O15173; Q9H2H9: SLC38A1; NbExp=3; IntAct=EBI-1050125, EBI-9978441;
CC       O15173; Q96H72: SLC39A13; NbExp=3; IntAct=EBI-1050125, EBI-10287091;
CC       O15173; Q86UD5: SLC9B2; NbExp=3; IntAct=EBI-1050125, EBI-9916342;
CC       O15173; O60906: SMPD2; NbExp=3; IntAct=EBI-1050125, EBI-12828299;
CC       O15173; Q96JF0-2: ST6GAL2; NbExp=3; IntAct=EBI-1050125, EBI-12908338;
CC       O15173; Q13277: STX3; NbExp=3; IntAct=EBI-1050125, EBI-1394295;
CC       O15173; P59542: TAS2R19; NbExp=3; IntAct=EBI-1050125, EBI-12847034;
CC       O15173; Q9NZ01: TECR; NbExp=3; IntAct=EBI-1050125, EBI-2877718;
CC       O15173; P02787: TF; NbExp=3; IntAct=EBI-1050125, EBI-714319;
CC       O15173; Q6UX40: TMEM107; NbExp=3; IntAct=EBI-1050125, EBI-12845616;
CC       O15173; Q14656: TMEM187; NbExp=3; IntAct=EBI-1050125, EBI-13046724;
CC       O15173; Q96HH6: TMEM19; NbExp=3; IntAct=EBI-1050125, EBI-741829;
CC       O15173; Q9BTX3: TMEM208; NbExp=3; IntAct=EBI-1050125, EBI-12876824;
CC       O15173; Q9H2L4: TMEM60; NbExp=3; IntAct=EBI-1050125, EBI-2852148;
CC       O15173; Q8N2M4: TMEM86A; NbExp=3; IntAct=EBI-1050125, EBI-12015604;
CC       O15173; Q8N661: TMEM86B; NbExp=3; IntAct=EBI-1050125, EBI-2548832;
CC       O15173; O60636: TSPAN2; NbExp=3; IntAct=EBI-1050125, EBI-3914288;
CC       O15173; O00124: UBXN8; NbExp=3; IntAct=EBI-1050125, EBI-1993850;
CC       O15173; Q9P0L0: VAPA; NbExp=5; IntAct=EBI-1050125, EBI-1059156;
CC       O15173; Q9BWQ6: YIPF2; NbExp=3; IntAct=EBI-1050125, EBI-751204;
CC       O15173; Q8IVQ6: ZDHHC21; NbExp=3; IntAct=EBI-1050125, EBI-2849773;
CC       O15173; O95159: ZFPL1; NbExp=3; IntAct=EBI-1050125, EBI-718439;
CC       O15173; P22315: Fech; Xeno; NbExp=2; IntAct=EBI-1050125, EBI-7174007;
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305|PubMed:23793472}; Single-
CC       pass membrane protein {ECO:0000305}. Nucleus envelope
CC       {ECO:0000269|PubMed:27754849, ECO:0000269|PubMed:28111073}. Endoplasmic
CC       reticulum {ECO:0000269|PubMed:27754849}. Secreted
CC       {ECO:0000269|PubMed:37453717}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=O15173-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O15173-2; Sequence=VSP_053500;
CC   -!- TISSUE SPECIFICITY: Expressed by endometrial glands and stroma (at
CC       protein level) (PubMed:23793472). Detected in urine (at protein level)
CC       (PubMed:37453717). {ECO:0000269|PubMed:23793472,
CC       ECO:0000269|PubMed:37453717}.
CC   -!- DOMAIN: The cytochrome b5 heme-binding domain lacks the conserved iron-
CC       binding His residues at positions 137 and 161. {ECO:0000250}.
CC   -!- MISCELLANEOUS: Non-classical progesterone receptors involved in
CC       extranuclear signaling are classified in 2 groups: the class II
CC       progestin and adipoQ receptor (PAQR) family (also called mPRs) (PAQR5,
CC       PAQR6, PAQR7, PAQR8 and PAQR9) and the b5-like heme/steroid-binding
CC       protein family (also called MAPRs) (PGRMC1, PGRMC2, NENF and CYB5D2).
CC       {ECO:0000303|PubMed:28396637}.
CC   -!- SIMILARITY: Belongs to the cytochrome b5 family. MAPR subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ002030; CAA05152.1; -; mRNA.
DR   EMBL; AK131272; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; DQ496105; ABF47094.1; -; Genomic_DNA.
DR   EMBL; BC016692; AAH16692.1; -; mRNA.
DR   EMBL; BC092478; AAH92478.1; -; mRNA.
DR   CCDS; CCDS3739.3; -. [O15173-1]
DR   RefSeq; NP_006311.3; NM_006320.6. [O15173-1]
DR   AlphaFoldDB; O15173; -.
DR   SMR; O15173; -.
DR   BioGRID; 115693; 318.
DR   FunCoup; O15173; 3156.
DR   IntAct; O15173; 198.
DR   MINT; O15173; -.
DR   STRING; 9606.ENSP00000481886; -.
DR   TCDB; 9.B.433.1.1; the progesterone receptor membrane-associated component 2 (pgrmc2) family.
DR   GlyGen; O15173; 2 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; O15173; -.
DR   MetOSite; O15173; -.
DR   PhosphoSitePlus; O15173; -.
DR   SwissPalm; O15173; -.
DR   BioMuta; PGRMC2; -.
DR   jPOST; O15173; -.
DR   MassIVE; O15173; -.
DR   PaxDb; 9606-ENSP00000429301; -.
DR   PeptideAtlas; O15173; -.
DR   ProteomicsDB; 48495; -. [O15173-1]
DR   Pumba; O15173; -.
DR   TopDownProteomics; O15173-1; -. [O15173-1]
DR   Antibodypedia; 27009; 277 antibodies from 32 providers.
DR   DNASU; 10424; -.
DR   Ensembl; ENST00000296425.10; ENSP00000296425.4; ENSG00000164040.18. [O15173-1]
DR   Ensembl; ENST00000520121.6; ENSP00000429301.2; ENSG00000164040.18. [O15173-1]
DR   Ensembl; ENST00000613358.4; ENSP00000481886.1; ENSG00000164040.18. [O15173-2]
DR   GeneID; 10424; -.
DR   KEGG; hsa:10424; -.
DR   MANE-Select; ENST00000296425.10; ENSP00000296425.4; NM_006320.6; NP_006311.3.
DR   UCSC; uc003igg.4; human. [O15173-1]
DR   AGR; HGNC:16089; -.
DR   CTD; 10424; -.
DR   DisGeNET; 10424; -.
DR   GeneCards; PGRMC2; -.
DR   HGNC; HGNC:16089; PGRMC2.
DR   HPA; ENSG00000164040; Low tissue specificity.
DR   MIM; 607735; gene.
DR   OpenTargets; ENSG00000164040; -.
DR   VEuPathDB; HostDB:ENSG00000164040; -.
DR   eggNOG; KOG1110; Eukaryota.
DR   GeneTree; ENSGT00940000159744; -.
DR   HOGENOM; CLU_042860_1_0_1; -.
DR   InParanoid; O15173; -.
DR   OrthoDB; 547796at2759; -.
DR   PAN-GO; O15173; 2 GO annotations based on evolutionary models.
DR   PhylomeDB; O15173; -.
DR   PathwayCommons; O15173; -.
DR   Reactome; R-HSA-8980692; RHOA GTPase cycle.
DR   Reactome; R-HSA-9013404; RAC2 GTPase cycle.
DR   Reactome; R-HSA-9013405; RHOD GTPase cycle.
DR   Reactome; R-HSA-9013408; RHOG GTPase cycle.
DR   Reactome; R-HSA-9013423; RAC3 GTPase cycle.
DR   Reactome; R-HSA-9707616; Heme signaling.
DR   SignaLink; O15173; -.
DR   BioGRID-ORCS; 10424; 37 hits in 1150 CRISPR screens.
DR   CD-CODE; 91857CE7; Nucleolus.
DR   ChiTaRS; PGRMC2; human.
DR   GenomeRNAi; 10424; -.
DR   Pharos; O15173; Tbio.
DR   PRO; PR:O15173; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; O15173; protein.
DR   Bgee; ENSG00000164040; Expressed in jejunal mucosa and 210 other cell types or tissues.
DR   ExpressionAtlas; O15173; baseline and differential.
DR   GO; GO:0012505; C:endomembrane system; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0020037; F:heme binding; IDA:UniProtKB.
DR   GO; GO:0015232; F:heme transmembrane transporter activity; IEA:Ensembl.
DR   GO; GO:0003707; F:nuclear steroid receptor activity; TAS:ProtInc.
DR   GO; GO:0005496; F:steroid binding; TAS:ProtInc.
DR   GO; GO:0060612; P:adipose tissue development; IMP:UniProtKB.
DR   FunFam; 3.10.120.10:FF:000003; membrane-associated progesterone receptor component 1; 1.
DR   Gene3D; 3.10.120.10; Cytochrome b5-like heme/steroid binding domain; 1.
DR   InterPro; IPR001199; Cyt_B5-like_heme/steroid-bd.
DR   InterPro; IPR036400; Cyt_B5-like_heme/steroid_sf.
DR   InterPro; IPR050577; MAPR/NEUFC/NENF-like.
DR   PANTHER; PTHR10281:SF24; MEMBRANE-ASSOCIATED PROGESTERONE RECEPTOR COMPONENT 2; 1.
DR   PANTHER; PTHR10281; MEMBRANE-ASSOCIATED PROGESTERONE RECEPTOR COMPONENT-RELATED; 1.
DR   Pfam; PF00173; Cyt-b5; 1.
DR   SMART; SM01117; Cyt-b5; 1.
DR   SUPFAM; SSF55856; Cytochrome b5-like heme/steroid binding domain; 1.
DR   neXtProt; NX_O15173; -.
PE   1: Evidence at protein level;
KW   Alternative splicing; Endoplasmic reticulum; Glycoprotein; Lipid-binding;
KW   Membrane; Nucleus; Phosphoprotein; Proteoglycan; Proteomics identification;
KW   Receptor; Reference proteome; Secreted; Steroid-binding; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..223
FT                   /note="Membrane-associated progesterone receptor component
FT                   2"
FT                   /id="PRO_0000121743"
FT   TRANSMEM        42..66
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          102..201
FT                   /note="Cytochrome b5 heme-binding"
FT   REGION          1..33
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          202..223
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        15..33
FT                   /note="Low complexity"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        206..215
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         90
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18691976, ECO:0007744|PubMed:19369195,
FT                   ECO:0007744|PubMed:19690332, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   MOD_RES         104
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         208
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         210
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0007744|PubMed:18669648"
FT   MOD_RES         211
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:18669648,
FT                   ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692,
FT                   ECO:0007744|PubMed:23186163, ECO:0007744|PubMed:24275569"
FT   CARBOHYD        15
FT                   /note="O-linked (Xyl...) (chondroitin sulfate) serine"
FT                   /evidence="ECO:0000269|PubMed:37453717"
FT   VAR_SEQ         1
FT                   /note="M -> MGGAGRGVGEGRGRGGGGRRWRAVM (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_053500"
SQ   SEQUENCE   223 AA;  23818 MW;  BE36229EDF0FF3AD CRC64;
     MAAGDGDVKL GTLGSGSESS NDGGSESPGD AGAAAEGGGW AAAALALLTG GGEMLLNVAL
     VALVLLGAYR LWVRWGRRGL GAGAGAGEES PATSLPRMKK RDFSLEQLRQ YDGSRNPRIL
     LAVNGKVFDV TKGSKFYGPA GPYGIFAGRD ASRGLATFCL DKDALRDEYD DLSDLNAVQM
     ESVREWEMQF KEKYDYVGRL LKPGEEPSEY TDEEDTKDHN KQD
//
